Literature DB >> 18592845

Investigation of an outbreak of chikungunya in Malegaon Municipal areas of Nasik district, Maharashtra (India) and its control.

Kaushal Kumar1, Mala Chhabra, R Katyal, P K Patnaik, Himani Kukreti, Arvind Rai, V K Saxena, V Mittal, Shiv Lal.   

Abstract

BACKGROUND &
OBJECTIVES: An outbreak of chikungunya fever occurred in Malegaon town of Nasik district of Maharashtra state, India during February and March 2006. A total of 4530 fever cases were reported during this period including 1781 cases which were admitted in different hospitals of the town. An entomological and epidemiological investigation was carried out in the affected villages during the outbreak to study the possible causes of the outbreak and to isolate the virus responsible.
METHODS: Entomological evaluation was done as per WHO guidelines. Sera samples were collected by venipuncture from clinically suspected chikungunya patients in hospitals and also during house-to-house survey in affected villages. IgM antibodies to dengue virus were detected using IgM capture ELISA (PANBIO) and by "Haemagglutination inhibition test" for detection of antibodies against Chikungunya virus. Acute sera samples were inoculated in cell lines for virus isolation. The isolates were confirmed by RT-PCR.
RESULTS: On investigation, it was found that water storage containers like cement tanks, plastic containers or earthen pots placed in front of the individual houses were the potential breeding sites for Aedes aegypti. Entomological survey carried out in the most affected areas revealed high Aedes indices. House, container and breteau indices were found to be 27.2, 16.19 and 35.1, respectively. Out of the 13 acute sera samples collected, virus was isolated in 10 samples. The isolates were confirmed by RT-PCR and sequencing using primers from nsP1 gene of Chikungunya virus (CHIKV, Accession No. EF077609, EF077610). Of the 17 convalescent sera tested, significant level of HI antibodies to CHIKV was detected in five samples. One sample was positive for IgM antibodies against dengue virus. Based on clinico-epidemiological features and laboratory findings, the illness was confirmed to be of chikungunya viral disease.
CONCLUSION: Control measures targeting the vector population and personal protective measures against the mosquito bites were instituted. Extensive IEC campaign with the involvement of community and religious leaders helped in containment of the disease.

Entities:  

Mesh:

Year:  2008        PMID: 18592845

Source DB:  PubMed          Journal:  J Vector Borne Dis        ISSN: 0972-9062            Impact factor:   1.688


  4 in total

1.  Enhanced larvicidal, antibacterial, and photocatalytic efficacy of TiO2 nanohybrids green synthesized using the aqueous leaf extract of Parthenium hysterophorus.

Authors:  Keerthika Thandapani; Manikandan Kathiravan; Elangovan Namasivayam; Indira Arulselvi Padiksan; Geetha Natesan; Manish Tiwari; Benelli Giovanni; Venkatachalam Perumal
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-23       Impact factor: 4.223

2.  Entomological investigation and control of a chikungunya cluster in Singapore.

Authors:  Cheong Huat Tan; Pei Sze Jeslyn Wong; Mei Zhi Irene Li; Siok Yin Sharon Tan; Tze Kwang Caleb Lee; Sook Cheng Pang; Sai Gek Lam-Phua; Nasir Maideen; Ah Bah Png; Sin Ying Koou; Deng Lu; Lee-Ching Ng
Journal:  Vector Borne Zoonotic Dis       Date:  2011-03-11       Impact factor: 2.133

3.  Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications.

Authors:  Rajpal S Kashyap; Shweta H Morey; Nitin H Chandak; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Cerebrospinal Fluid Res       Date:  2010-08-13

4.  The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines.

Authors:  Alison A Bettis; Maïna L'Azou Jackson; In-Kyu Yoon; J Gabrielle Breugelmans; Ana Goios; Duane J Gubler; Ann M Powers
Journal:  PLoS Negl Trop Dis       Date:  2022-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.